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Abstract
Background: The lung and thyroid are derived from the anterior endoderm. Retinoic acid and Fgf signalling are
known to be essential for development of the lung in mouse but little is known on how the lung and thyroid are
specified in Xenopus.
Results: If either retinoic acid or Fgf signalling is inhibited, there is no differentiation of the lung as assayed by
expression of sftpb. There is no change in expression of thyroid gland markers when retinoic acid signalling is
blocked after gastrulation and when Fgf signalling is inhibited there is a short window of time where pax2
expression is inhibited but expression of other markers is unaffected. If exogenous retinoic acid is given to the
embryo between embryonic stages 20 and 26, the presumptive thyroid expresses sftpb and sftpc, specific markers
of lung differentiation and expression of key thyroid transcription factors is lost. When the presumptive thyroid is
transplanted into the posterior embryo, it also expresses sftpb, although pax2 expression is not blocked.
Conclusions: After gastrulation, retinoic acid is required for lung but not thyroid differentiation in Xenopus while
Fgf signalling is needed for lung but only for early expression of pax2 in the thyroid. Exposure to retinoic acid can
cause the presumptive thyroid to switch to a lung developmental program.
Background
The differentiation of specific organs from the endo-
derm is directly related to their position along the ante-
roposterior axis of the vertebrate embryo. After initial
specification of the endoderm, wnt, nodal, bone mor-
phogenetic protein and fibroblast growth factor (Fgf)
signals quickly subdivide the gut into the foregut, mid-
gut and hindgut [1]. Expression of hhex, sox2 and foxa2
are associated with the foregut [2] whereas expression of
sox17 [3] and cdx [4] genes is eventually restricted to
posterior endoderm. The foregut will give rise to the
thyroid, thymus, parathyroid, lung, liver, pancreas, and
stomach.
Although specific transcription factors are associated
with each of these organ systems in later development,
expression of key transcription factors at early stages is
not restricted to a specific organ system. In the foregut,
nkx2.1 (or ttf1) is required for development of both the
lung and thyroid suggesting a close relationship between
these tissues but each organ has a distinct set of tran-
scription factors that are required for differentiation.
The thyroid also expresses hhex, pax8,a n dfoxe1 [5],
although in Xenopus and zebrafish, pax2 is the Pax gene
expressed in the thyroid [6,7]. In addition to nkx2.1,t h e
lung expresses foxa2 and foxp2 [8-10]. The interplay of
many different signalling pathways is necessary for
defining both of these organs. Fibroblast growth factor
(Fgf) signalling has been shown to be essential for both
thyroid [11] and lung although the signal amplitude and
timing are important for determining the output from
the Fgf signal [12].
Recently, in addition to Fgf signalling, it has been
demonstrated that graded levels of retinoic acid (RA)
are important in chick for defining the different regions
along the anterior-posterior axis of the developing endo-
derm [13]. The most anterior endoderm, that gives rise
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any medium, provided the original work is properly cited.to the thyroid, forms with little or no RA although RA is
necessary for other anterior endoderm derivatives
including the lung [14,15] and pancreas [16,17]. In frog,
aldh1a2 (raldh2), encoding the enzyme primarily
responsible for the synthesis of RA, is expressed dyna-
mically throughout development. After gastrulation
when patterning of the gut is being established, expres-
sion is found in the lateral plate mesoderm overlying
the anterior gut with highest levels on the dorsal side.
There are discrete regions of expression in the head but
on the ventral side, there is little expression anterior to
the forming heart [18,19]. This would predict that the
forming lung should be exposed to RA but that more
posterior endoderm would be exposed to lower levels of
RA. The most anterior endoderm, giving rise to the
thyroid, should also have limited exposure to RA. Later
in development, expression of aldh1a2 is found in speci-
fic gut regions where it is required for the gut looping
process [20].
In Xenopus, differentiation markers that can be used
to study development of the lung have only recently
been identified [21]. In that study, surfactant protein B
(sftpb)a n dsurfactant protein C (sftpc)w e r es h o w nt o
have high sequence conservation with other homologues
and were surprisingly early markers of lung in Xenopus,
being expressed as early as stage 39. Sftpb and sftpc
encode important constituents of pulmonary surfactant,
a material that regulates s u r f a c et e n s i o ni nt h el u n g
alveoli and are expressed solely in the lung [22].
A l t h o u g ht h er o l eo ft h y r o i dh o r m o n ei nXenopus biol-
ogy has been extensively studied [23], the development
of the thyroid is not well characterized. Expression stu-
dies have demonstrated key early transcription factors,
identified as essential in other organisms, likely play a
role in thyroid development in Xenopus including
nkx2.1 [24], pax genes [6,25], foxe1,a n dfoxe4 [25], but
how the thyroid is specified in frog is not known.
The goal of this study was to test the hypothesis that
the underlying mechanism for the development of the
lung and thyroid in Xenopus is similar to other model
organisms. In doing so, we demonstrate that the
requirement for RA and Fgf signalling in lung differen-
tiation is conserved in Xenopus. Furthermore, if exogen-
ous retinoic acid is applied to the embryo after
gastrulation, the thyroid primordium will express sftpb
and sftpc. In addition, expression of early transcription
factors that are normally expressed in the thyroid but
not the lung, pax2, foxe4, and hhex are lost in presump-
tive thyroid in response to retinoic acid. These results
further demonstrate that spatial control of specific sig-
nalling factors is essential for the patterning of the fore-
gut endoderm and that retinoic acid signalling is a key
element of that process.
Results
Temporal expression of lung and thyroid markers
To establish a baseline of when the different markers of
lung and thyroid are first detectable, their expression
was compared by whole mount in situ hybridization
(Figure 1). Nkx2.1 expression was first detectable in the
thyroid at stage 30 and appeared as a small dot immedi-
ately caudal to the cement gland. There was only a
slight delay before expression of pax2 was detected in
t h et h y r o i d .A ts t a g e3 4 ,e x p r e s s i o no fnkx2.1 was
detectable in the forming lung. As expected, the expres-
sion of these key transcription factors preceded the
expression of the lung differentiation markers sftpb and
sftpc both of which were detectable at stage 38.
Retinoic acid and FGF are required for lung development
in Xenopus
A requirement for both RA and Fgf signalling has been
demonstrated in mouse lung development [26-29] and
we wished to confirm that this requirement is conserved
in Xenopus. Using a pan-retinoic acid receptor antago-
nist [30], we were able to show that there is a require-
ment for RA signalling. However, the ability of the
antagonist to suppress lung differentiation, as assayed by
sftpb expression is restricted to very early stages of lung
development. If RA signalling was blocked at stage 26,
well before the expression of nkx2.1, lung differentiation
occurred normally (Figure 2). Expression of sftpb was
detectable in some embryos when RA signalling was
blocked as early as stage 20, although most had no
expression and those that did had lower expression
levels than control embryos. These results are mirrored
by the expression of nkx2.1. If RA signalling is blocked
prior to stage 20, nkx2.1 expression is lost in the lung
although maintained in the thyroid. At stage 20 there is
lung expression in some embryos and if treatment with
the RA antagonist is delayed until stage 26, essentially
all embryos express nkx2.1 in the lung.
If Fgf signalling was blocked using the inhibitor
SU5402 after stage 12, 20, or even stage 26, expression
of nkx2.1 was lost in the lung region whereas the
expression in the forming thyroid was maintained (Fig-
ure 3). Again, as expected, blocking Fgf signalling also
resulted in a loss of sftpb expression, although some
embryos did show some very weak sftpb expression
(Additional File 1, Figure S1). The loss of Fgf signalling
was also confirmed by looking at the expression of spro-
uty2, a direct target of Fgf signalling (Additional File 1,
Figure S1). In addition, expression of foxe4 was main-
tained in the forming thyroid in the presence of
SU5402. This suggests that Fgf signalling was required
for lung specification but not thyroid specification at the
times tested. Expression of foxe4 in the forming lens
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Page 2 of 12Figure 1 Temporal expression of lung and thyroid markers. Whole mount in situ hybridization was used to compare the temporal
expression of key early genes in the development of the thyroid and lung. Expression of nkx2.1 is first detectable in the thyroid (red arrows) at
stage 30 and is subsequently expressed in the lung (green arrows) at stage 34. Expression of pax2 begins at stage 32 in the thyroid. Expression
of the differentiation markers sftpb and sftpc is first detectable at stage 38.
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Page 3 of 12was maintained when FGF signalling was blocked but
the lens morphology was aberrant when compared to
controls in Fgf inhibitor treatments that began at stage
20 (Figure 3). Given that Fgf signalling has been impli-
cated in thyroid development in other organisms [7], we
also looked at the expression of the other early thyroid
marker, pax2. We found that blocking Fgf signalling
immediately after gastrulation (stage12) resulted in no
thyroid expression of pax2, although expression in other
tissues remained unaffected (Figure 3). When Fgf signal-
ling was blocked at stage 20, pax2 expression in the
thyroid was apparently normal, although expression was
not observed in all embryos. Treatment at stage 26 had
no effect on pax2 expression in the thyroid.
Exogenous retinoic acid causes the thyroid to express the
lung developmental program
As the requirement for RA was very early in the process
of lung organogenesis, one potential role for retinoic
acid could be to determine the number of lung progeni-
tors. Therefore, we also treated embryos with exogenous
retinoic acid to see if there was an increase in the size
of the developing lung. Although we did not see any
clear increase in lung size, there was ectopic expression
of sftpb in a small region of the embryo that
corresponded both in size and shape with the develop-
ing thyroid (Figure 2). Addition of RA was able to cause
this ectopic expression even when retinoic acid was
added as late as stage 34 and the activity was dose
dependent (Table 1). Concentrations of RA that were
able to cause ectopic expression of sftpb were the same
as those that caused loss of pax2 expression in the thyr-
oid suggesting that the two processes might be linked
(Table 1). When embryos were treated with RA at stage
14, there was no ectopic expression of sftpb posterior to
the cement gland (Figure 2) although there was also no
expression of pax2 or foxe4.
In order to determine if this simply represented ecto-
pic expression of sftpb in the thyroid or a more global
change towards lung differentiation in the thyroid, we
examined expression of sftpc, another highly specific
lung specific marker and found that it was also
expressed in the thyroid primordium when embryos
were exposed to RA (Figure 4). The presence of sftpb
and sftpc mRNA suggests either that RA causes lung dif-
ferentiation markers to be expressed in the thyroid or
that it causes the conversion of presumptive thyroid tis-
sue into lung. To distinguish between these possibilities,
we examined the expression of the key early transcrip-
tion factors in lung and thyroid development in
Figure 2 Retinoic acid is required for lung differentiation but excess retinoic acid causes expression of lung differentiation markers in
the thyroid. When embryos were treated with a retinoic acid antagonist (RAA) at stage 14 of development, the lung failed to differentiate as
judged by the lack of sftpb expression at stage 38/40. If the retinoic acid antagonist is not added until stage 26, the expression of sftpb in the
lung was essentially normal. If embryos were exposed to exogenous retinoic acid (RA) starting between stages 20 to 34, expression of sftpb was
detectable in both the lung (green arrows) and in the thyroid (red arrow). Addition of retinoic acid at earlier (stage 14) or later stages (stage 36)
did not result in expression of sftpb in the presumptive thyroid. Carrier control (DMSO) embryos had normal expression of sftpb. Treatment times
are indicated at the top of each column (eg. T-st14 indicates that the treatment was initiated at embryonic stage 14).
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Page 4 of 12response to treatment with retinoic acid. As nkx2.1 is
expressed in both the early thyroid and lung, it was per-
haps not surprising that there was no difference in
expression of nkx2.1 when embryos were exposed to RA
or when RA signalling was blocked using the RA inhibi-
tor at stage 26 (Figure 5). However, pax2 and foxe4,b o t h
markers of the early thyroid are not expressed in the
thyroid in RA treated embryos, although expression at
other sites is not lost in the same embryos. Foxe1 has
been described as another early marker of the thyroid
[ 2 5 ]b u tw ef i n dt h a ti td o e sn o th a v et h es a m es t r o n g
midline expression seen with other thyroid markers,
although we cannot rule out low levels of expression.
Nevertheless, RA had no discernable effect on expression
of foxe1 in that region although some patterning differ-
ences were noted in the pharyngeal region (Figure 5).
Hhex is a homeobox-containing transcription factor
that is first expressed in a broad domain in the anterior
endoderm and expression then becomes restricted to the
forming thyroid and liver [1,31]. Exposure to retinoic
acid during late gastrulation is known to eliminate hhex
expression in the thyroid [16] and we wanted to ensure
that our later retinoic acid treatments would still result
in loss of thyroid expression. Treatment with RA at stage
26 was also able to eliminate the expression of hhex in
the thyroid without loss of expression in the liver (Figure
6), further suggesting that RA blocks the full repertoire
of early thyroid transcription factors. We also examined
whether blocking RA signalling would change hhex
expression. If RA signalling was blocked between stage
14 and 26, there was no obvious change in hhex expres-
sion in either the liver or thyroid (Figure 6).
Although addition of RA as late as stage 34 resulted in
expression of sftpb in the presumptive thyroid, if the
retinoic acid was added between stages 32 and 34, there
Figure 3 Fgf signalling is required for lung and elements of thyroid differentiation in Xenopus. When embryos were treated with SU5402
at either stage 12, 20 or 26, expression of nkx2.1 was lost in the lung (green arrows) but not the thyroid (red arrows) or anterior neural tissue.
Although treatment with SU5402 at stage 20 caused clear deformations in the lens ectoderm expression (yellow arrows) of foxe4, there was no
clear effect on the thyroid expression of foxe4. Expression of pax2 in the thyroid was lost when SU5402 was applied at stage 12 but expression
of pax2 was observed in most embryos at stage 20 and all embryos when treated at stage 26. Note the severe tail defects in embryos treated
with SU5402 at stage 12 demonstrating the effectiveness of the block to Fgf signalling. (side - side view, ventral - ventral view).
Table 1 Presence of pax2 and sftpb expression in the
presumptive thyroid exposed to different concentrations
of RA
1 μM RA 0.1 μM RA 0.01 μM RA DMSO control
pax2 0/60 32/61 54/64 54/54
sftpb 74/83 63/84 37/81 0/75
The numbers represent the number of embryos expressing the gene in the
thyroid over the total number of embryos examined.
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Page 5 of 12was no loss of pax2 and foxe4 expression. This suggests
that the tissue becomes ambiguous, expressing tran-
scription factors that define it as thyroid in addition to
the lung differentiation markers (Table 2).
One simple model for explaining differentiation of
the thyroid might be that gastrulation movements
position the presumptive thyroid far enough towards
the rostral end of the embryo that it is not exposed to
retinoic acid. If so, we would predict that simply
transplanting the presumptive thyroid to the flank of
t h ee m b r y o ,w h e r et h e r ei sr o b u s taldh1a2 expression,
may be sufficient to cause those precursors to differ-
entiate as lung. This would also directly test whether
endogenous levels of retinoic acid would be sufficient
to cause the thyroid to lung switch. When presumptive
thyroid explants were removed and cultured to stage
38 they did not express sftpb but robust expression of
pax2 could be seen in the cultured explants (Figure
Figure 4 Exogenous retinoic acid causes ectopic expression of sftpc in the presumptive thyroid. Whole mount in situ hybridization for
sftpc demonstrated that embryos treated at stage 26 with exogenous retinoic acid showed ectopic expression of sftpc in the developing thyroid
(red arrows) as well as the normal expression in the lung (green arrows). (side - side view, ventral - ventral view).
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of a donor embryo and allowed to heal, the explants
could be seen to express sftpb (Figure 7C, E) suggest-
ing that endogenous levels of RA can cause the pre-
sumptive thyroid to express sftpb.H o w e v e r ,t h e
transplants also continued to express pax2 suggesting
that, similar to when RA is added between stages 30
and 34, the tissue has not lost all thyroid characteris-
tics (Figure 7D,F). The size of the expression domain
also corresponded well with the normal size of the
thyroid suggesting that it was only the presumptive
thyroid domain that was expressing sftpb.
Discussion
RA and FGF are required for lung development in
Xenopus
Little is known about the signalling mechanisms
required for lung development in Xenopus. A recent
study has suggested that wnt and hedgehog signalling
are needed for later lung development based on the
expression patterns of shh, wnt7b, wnt5a and wif1 but
their functional roles have yet to be elucidated. Here we
show that both RA (Figure 2) and Fgf (Figure 3) signal-
ling are necessary for differentiation of the lung in Xeno-
pus. Both of these signalling systems are required for
Figure 5 Exogenous retinoic acid signalling results in the loss of early thryroid gene expression. When embryos are treated with retinoic
acid (RA) at stage 24/26, expression of sftpb was detected in the thyroid (red arrows) and in the lung (green arrows) but it is only expressed in
the lung in control (DMSO) embryos. Pax2 and foxe4 are normally expressed in the thyroid although both have distinct expression domains in
other tissues. Embryos treated with RA still expressed both pax2 and foxe4 but the expression in the thyroid was eliminated. Expression of foxe1
could be observed in all embryos, particularly in the pharynx, but expression in the thyroid was undetectable. Treatment with the retinoic acid
antagonist at stage 26 did not eliminate the expression of any tested markers in either the thyroid or lung.
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Page 7 of 12lung differentiation in the mouse and the two systems
have been linked as loss of RA results in reduced levels
of Fgf10 and subsequent lung agenesis [14]. It would
appear that both RA and Fgf are very high in the
hierarchy of lung specification as both are required well
before the initial expression of nkx2.1.
The requirement for RA signalling is lost quite early
in the development of the lung. If the antagonist is
added as early as stage 20, well before the expression of
nkx2.1, there is still detectable expression of sftpb.I ft h e
antagonist is added at stage 26, the expression of sftpb
is essentially the same as control embryos. The sftpb
promoter in humans has binding sites for both retinoic
acid receptors and for nkx2.1 and the two transcription
factors act synergistically to drive expression of sftpb
[32]. Although we cannot make any conclusions regard-
ing the levels of sftpb expression using whole mount in
situ hybridization, our results demonstrate that the acti-
vation of the retinoic acid receptors by RA is not a
requirement for sftpb expression.
The requirement for Fgf also occurs early in Xenopus
as blocking Fgf signalling at stage 20 causes a loss of
nkx2.1 expression, although unlike RA, the require-
ment is maintained later as blocking at stage 26 still
showed a complete loss of nkx2.1 (Figure 3) and subse-
quent sftpb expression (Additional File 1, Figure S1) in
the lung.
Figure 6 Treatment with retinoic acid eliminated expression of hhex in the thyroid but not liver. When embryos were treated at stage
24/26 and cultured to stage 36, expression could be detected near the thyroid even in RA treated embryos but in ventral view it can be clearly
seen that midline expression of hhex (red arrow) is eliminated by RA but there is an additional region of expression lateral to the thyroid (blue
arrows) that is not lost when embryos were treated with RA. There is also no obvious change in the expression of the large liver expression
domain found caudal to the thyroid expression.
Table 2 Effect of RA on presence of sftpb, pax2 and foxe4
expression in specific organs
sftpb expression pax2 expression foxe4 expression
Treatment Lung Thyroid Thyroid Kidney Thryoid Eye
St. 14 DMSO 33/33 0/33 10/10 10/10 11/11 11/11
St. 14 RA 32/32 0/32 0/11 11/11 0/10 0/10
St. 26 DMSO 82/82 0/82 70/70 70/70 50/50 50/50
St. 26 RA 81/82 78/82 0/74 74/74 0/54 54/54
St. 30 DMSO 22/22 0/22 12/12 12/12 9/12 12/12
St. 30 RA 24/26 20/26 2/11 11/11 2/11 11/11
St. 32 DMSO 42/42 0/42 26/26 26/26 24/24 24/24
St. 32 RA 39/40 39/40 21/25 25/25 23/23 23/23
St. 34 DMSO 6/6 0/6 10/10 10/10 28/28 28/28
St. 34 RA 5/5 5/5 10/10 10/10 16/16 16/16
St. 36 DMSO 6/6 0/6 10/10 10/10 10/10 10/10
St. 36 RA 6/6 0/6 10/10 10/10 10/10 10/10
The numbers represent the number of embryos expressing the gene in the
organ examined over the total number of embryos examined.
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Page 8 of 12Figure 7 Transplantation of the presumptive thyroid explants into the embryo flank is sufficient to cause expression of sftpb in the
explant. When explants of the presumptive thyroid region are cultured alone, they do not express sftpb (A) but do express pax2 (B - black
arrows). Note that the small blue flecks are seen on the surface of many embryos due to the stickiness of the cement gland that is also usually
in part of the explant. When those same explants are placed on to the flank region immediately after they are removed from donor embryos,
sftpb expression can be seen in the explant (blue arrows) as well as the endogenous lung (green arrows). When explants are transplanted,
expression of pax2 (red arrows) can be seen in the explants. Embryos in C and D are normal views and embryos in E and F have been cleared
to better visualize staining although cavity staining is also seen when embryos are cleared.
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Page 9 of 12Requirements of RA and Fgf signalling for development
of the thyroid gland
When RA signalling was blocked, expression of thyroid
markers was not affected (Figure 5). In mouse, Fgf8,
regulated by tbx1 and arising from the secondary heart
field, is required for normal thyroid development
although loss of fgf8 did not eliminate the thyroid [11].
In zebrafish, hand2 is upstream of fgf8 and this pathway
is essential for thyroid development and again it is the
cardiac mesoderm that is the source of the Fgf signal
[7]. Thus it is surprising that the SU5402 treatments
had little effect on expression of either nkx2.1 or foxe4,
although it was clear that SU5402 was able to cause
developmental defects in the treated embryo, including
loss of nkx2.1 expression in the lung, severe loss of tail
(Figure 3) and loss of sprouty2 expression (Additional
File 1, Figure S1).
We did find that the expression of pax2 in the thyroid
was lost with early SU5402 treatments. The thyroid itself
does not appear to be a direct target of the Fgf signal in
zebrafish [7]. If the potential intermediate tissue were
already established before we treated with SU5402 in
Xenopus, this could provide an explanation for the lack
of effect on nkx2.1 and foxe4 expression. Identification
of the intermediate tissue is needed in order to test this
possibility. The lack of pax2 expression while nkx2.1
and foxe4 expression is maintained is perhaps expected.
In pax8 knockout mice, the early thyroid primordium is
maintained with normal nkx2.1 expression although the
thyroid is eventually lost at later stages due to apoptosis
[5,33]. Thus, eventual loss of the thyroid might even-
tually be expected in Xenopus when Fgf signalling is
blocked at very early stages.
RA causes presumptive thyroid tissue to express lung-
specific markers
We have observed that addition of exogenous RA results
in expression of sftpb and sftpc in the thyroid (Figure
2,4), both of which are clear markers of the differen-
tiated lung. This does not seem to be simple ectopic
expression as thyroid expression of hhex, pax2,a n d
foxe4 are lost with the addition of RA (Figure 5,6).
Hhex, pax8, foxe4,a n dnkx2.1 have been identified as
forming a key transcription factor network for maintain-
ing the thyroid [5] and it appears that a similar network
exists in Xenopus. Pax2 substitutes for the expression of
pax8 [6] and based on our expression data, it appears
that foxe4 is more closely related to the central thyroid
region than foxe1 (Figure 5). Nevertheless, the early
thyroid markers that we have examined are lost with the
addition of RA suggesting that there has been a loss of
the thyroid developmental program. The one exception
is that expression of nkx2.1 is maintained but it is also
normally expressed in the lung. The suppression of hhex
expression by exogenous RA has also been observed in
the chick although in that system there was also loss of
nkx2.1 expression [13] suggesting that RA is sufficient
to block thyroid development but not able to cause the
fate switch that we observe in Xenopus.I nt h es a m e
chick study it was concluded that the thyroid must form
in the absence or at very low levels of RA [13]. Our
results confirm this and suggest that in Xenopus,t h e
absence of RA is actually required for thyroid develop-
ment, as presence of RA would result in potential differ-
entiation as lung tissue.
We were not able to look at any differentiation mar-
kers of thyroid. Although thyroid hormone has been
extensively studied in terms of metamorphosis in Xeno-
pus, little is known about the ontogeny of the enzymes
required for thyroid hormone production. A study
examining the expression of thyroid peroxidase, type II
idothyronine deiodinase, and type III iodothyronine
deiodinase showed that none of these were expressed in
the thyroid before stage 41 [34]. Interestingly, although
initially described as thyroid gland expression, thyroid
peroxidase is expressed in the lung at stage 43 [34]
further demonstrating the close relationship between
these two organs. We also hoped to determine whether
RA-treated thyroid progenitors would form structures
reminiscent of a mature lung such as branching or
alveoli. However, these are very late events in Xenopus
development [35] and embryos treated with RA usually
developed swelling around the heart that did not allow
culturing to later stages.
The recent finding that sfrp5 and wnt11, both linked
to the planar cell polarity pathway [36,37], are necessary
for foregut specification suggests that morphogenetic
movements of the endoderm may be important for
proper specification of the different organ systems [38].
The requirement for morphogenesis suggests a relatively
simple model whereby the early movements of the
endoderm simply result in the furthest anterior endo-
derm, the presumptive thyroid, being beyond the meso-
dermal domains where retinoic acid is being
synthesized. By simply physically moving the presump-
tive thyroid endoderm back to regions that would be
predicted to have high levels of RA, the transplanted
endoderm was able to express lung differentiation mar-
kers (Figure 7). However, we cannot rule out the possi-
bility that other factors, present in the posterior embryo,
might also be responsible for the transition.
Conclusions
Both RA and FGF signalling are required for the differ-
entiation of the lung in Xenopus embryos. RA is
required for lung development before the lung primor-
dium expresses nkx2.1 and sftpb can still be expressed
in embryos that are treated with an RA antagonist in
Wang et al. BMC Developmental Biology 2011, 11:75
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Page 10 of 12later development. If the presumptive thyroid is exposed
to RA before stage 20, early thyroid transcription factors
are suppressed and lung differentiation markers will be
expressed in the presumptive thyroid.
Methods
Embryo Collection
Female Xenopus laevis frogs were injected with 600-700
IU of human chorionic gonadotrophin (Sigma) to induce
ovulation. In vitro fertilization of ovulated eggs was per-
formed in 80% Steinberg’s solution containing minced
testis. Embryos were dejellied with 2.5% cysteine, pH
8.0, and cultured in 20% Steinberg’s solution. Embryos
were staged according to the Nieuwkoop and Faber sta-
ging table [35].
Cloning of sftpb and sftpc
Adult Xenopus laevis lung cDNA was used to amplify
both sftpb and sftpc. The initial clones were amplified by
polymerase chain reaction using the following
sequences: sftpb forward 5’-cagtgggtccacaggatgac-3’ and
reverse 5’-gacggccccacactctttag-3’ and sftpc forward 5’-
ggctgcacatgagtcaaaaac-3” and reverse 5’-ctgttccggatc-
catttgtg-3’. The sequence obtained from the sftpb ampli-
con was used to generate new primers for a 5’ rapid
amplification of cDNA ends procedure that gave a
longer cDNA clone that included the start codon.
Sequencing of the clone showed that it matched pre-
viously identified sftpb sequence (Genbank Ref.
NM_001096917.1). The sftpc sequence matched the pre-
viously identified sftpc sequence (Genbank Ref
NM_001096721.1).
Embryo Treatments
Embryos were treated with 1μM all-trans RA (Sigma) or
1μM pan RAR antagonist (Allergan #193109) [30,39] in
20% Steinberg’s solution at various stages depending on
the experiment. Stock solutions for both RA and RAA
were 1mM dissolved in DMSO, and therefore a control
treatment was performed with 0.1% DMSO in 20%
Steinberg’s solution. Fgf signaling was inhibited by the
addition of 10μM SU5402 (EMB Biosciences) in the pre-
sence of 100 μM ATP. Control treatments were DMSO
and ATP alone.
Explants were removed at stage 18/20 using the
cement gland as a guide. Explants were cut and main-
tained in 1 × MBS. Explants were transplanted by creat-
ing a small wound in the recipient embryo at the site
for transplantation and the transplantation was also con-
ducted in 1× MBS. After the explant had healed, the
embryos were transferred back to 20% Steinberg’s
solution.
In situ Hybridization
Whole-mount in situ hybridizations were performed
according to [40] with modifications: embryos were
blocked in Tris buffered saline, 20% heat treated sheep
serum; and the Proteinase K, and RNase A steps were
omitted. Antisense Dig-labelled riboprobes for sftpb and
sftpc w e r eg e n e r a t e db yc u t t i n gt h ep l a s m i d sw i t hXba1
and transcribing with SP6 RNA polymerase according to
established protocols [40]. Antisense Dig-labelled ribop-
robes for pax2a [6], foxe1, foxe4, [25], nkx2.1 [24], and
hhex [41] were also generated using the same methods.
BM Purple (Roche Diagnostics) was used as the alkaline
phosphatase substrate throughout and embryos were
fixed for twenty minutes in MEMPFA before removing
endogenous pigment in 1% hydrogen peroxide, 5% for-
mamide, and 0.5%SSC for several hours after the colour
reaction. For some images, the embryos were cleared by
immersion in 1 part benzyl alcohol: 2 parts benzyl
benzoate after dehydration in methanol. Embryos were
visualized using a Leica MZ12 dissecting microscope
and images were taken using Northern Eclipse software
(Empix Imaging; Mississauga, ON, Canada).
Additional material
Additional file 1: Treatment with SU5402 causes a loss of both
sftpb and sprouty2 expression. Embryos treated with SU5402, in order
to block Fgf signalling, do not express sftpb indicating that there is a loss
of differentiated lung. The location of the differentiated lung (green
arrow) can be seen in the control embryo (DMSO treated). Expression of
sprouty2 (spry2) was used to demonstrate the effectiveness of the Fgf
signalling block. Sprouty2 is a target of Fgf signalling and strong
expression can normally be seen at the midbrain-hindbrain border
(yellow arrow) and in the pharynx (purple arrow). The expression of
sprouty2 in these regions is effectively eliminated by addition of SU5402
at all times tested. Treatment times are indicated at the top of each
column (eg. T-st12 indicates that the treatment was initiated at
embryonic stage 12).
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